Detailed information for compound 405857

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 1251.82 | Formula: C57H83ClN16O14
  • H donors: 13 H acceptors: 15 LogP: -3.83 Rotable bonds: 31
    Rule of 5 violations (Lipinski): 4
  • SMILES: NCCCC[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CC(=O)N(C(=O)[C@@H]2N(C1=O)CCC2)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC)Cc1ccc(cc1)Cl)Cc1cccnc1
  • InChi: 1S/C57H83ClN16O14/c1-5-36(65-32(4)75)48(80)70-41(26-33-15-17-35(58)18-16-33)52(84)71-42(27-34-11-8-22-63-29-34)53(85)72-43-28-46(77)74(30-45(60)76)56(88)44-14-10-24-73(44)55(87)39(12-6-7-21-59)68-51(83)40(25-31(2)3)69-49(81)37(13-9-23-64-57(61)62)66-50(82)38(67-54(43)86)19-20-47(78)79/h8,11,15-18,22,29,31,36-44H,5-7,9-10,12-14,19-21,23-28,30,59H2,1-4H3,(H2,60,76)(H,65,75)(H,66,82)(H,67,86)(H,68,83)(H,69,81)(H,70,80)(H,71,84)(H,72,85)(H,78,79)(H4,61,62,64)/t36-,37-,38+,39-,40+,41-,42-,43+,44+/m0/s1
  • InChiKey: BYKKKXQKCFIVJX-SZHCBFCVSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Gonadotropin-releasing hormone receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi GnHR receptor homolog Get druggable targets OG5_131719 All targets in OG5_131719

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Gonadotropin-releasing hormone receptor   327 aa 343 aa 21.6 %
Echinococcus multilocularis neuropeptide receptor Gonadotropin-releasing hormone receptor   327 aa 263 aa 20.9 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Gonadotropin-releasing hormone receptor   327 aa 263 aa 23.2 %
Onchocerca volvulus Gonadotropin-releasing hormone receptor   327 aa 336 aa 20.8 %
Echinococcus granulosus allatostatin A receptor Gonadotropin-releasing hormone receptor   327 aa 284 aa 22.9 %
Onchocerca volvulus Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog Gonadotropin-releasing hormone receptor   327 aa 273 aa 19.8 %
Loa Loa (eye worm) hypothetical protein Gonadotropin-releasing hormone receptor   327 aa 334 aa 21.6 %
Schistosoma mansoni peptide (allatostatin)-like receptor Gonadotropin-releasing hormone receptor   327 aa 272 aa 23.2 %
Schistosoma japonicum 5-hydroxytryptamine receptor 4, putative Gonadotropin-releasing hormone receptor   327 aa 305 aa 24.9 %
Onchocerca volvulus Gonadotropin-releasing hormone receptor   327 aa 284 aa 19.4 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Gonadotropin-releasing hormone receptor   327 aa 288 aa 24.3 %
Echinococcus multilocularis tachykinin peptides receptor 99D Gonadotropin-releasing hormone receptor   327 aa 283 aa 20.1 %
Onchocerca volvulus Gonadotropin-releasing hormone receptor   327 aa 292 aa 19.5 %
Schistosoma japonicum Alpha-1A adrenergic receptor, putative Gonadotropin-releasing hormone receptor   327 aa 290 aa 19.7 %
Onchocerca volvulus E3 ubiquitin-protein ligase rpm-1 homolog Gonadotropin-releasing hormone receptor   327 aa 288 aa 27.8 %
Schistosoma mansoni neuropeptide receptor Gonadotropin-releasing hormone receptor   327 aa 263 aa 24.0 %
Echinococcus granulosus tm gpcr rhodopsin Gonadotropin-releasing hormone receptor   327 aa 299 aa 23.1 %
Onchocerca volvulus Gonadotropin-releasing hormone receptor   327 aa 271 aa 20.7 %
Echinococcus granulosus tachykinin peptides receptor 99D Gonadotropin-releasing hormone receptor   327 aa 283 aa 19.1 %
Brugia malayi ORL1-like opioid receptor Gonadotropin-releasing hormone receptor   327 aa 293 aa 20.8 %
Echinococcus multilocularis allatostatin A receptor Gonadotropin-releasing hormone receptor   327 aa 279 aa 23.7 %
Onchocerca volvulus Gonadotropin-releasing hormone receptor   327 aa 336 aa 19.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0599 0.5 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0599 0.5 0.5
Mycobacterium tuberculosis Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) 0.0599 0.5 0.5
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0599 0.5 0.5
Toxoplasma gondii eukaryotic initiation factor-4A, putative 0.0599 0.5 0.5
Entamoeba histolytica DEAD/DEAH box helicase, putative 0.0599 0.5 0.5
Plasmodium vivax RNA helicase-1, putative 0.0599 0.5 0.5
Plasmodium falciparum eukaryotic initiation factor 4A 0.0599 0.5 0.5
Leishmania major eukaryotic initiation factor 4a, putative 0.0599 0.5 0.5
Echinococcus multilocularis eukaryotic initiation factor 4A 0.0599 0.5 0.5
Echinococcus granulosus eukaryotic initiation factor 4A 0.0599 0.5 0.5
Echinococcus multilocularis eukaryotic initiation factor 4A III 0.0599 0.5 0.5
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0599 0.5 0.5
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0599 0.5 0.5
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0599 0.5 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0599 0.5 0.5
Treponema pallidum ATP-dependent RNA helicase 0.0599 0.5 0.5
Onchocerca volvulus Eukaryotic initiation factor 4A homolog 0.0599 0.5 0.5
Echinococcus granulosus eukaryotic initiation factor 4A III 0.0599 0.5 0.5
Trypanosoma brucei Eukaryotic initiation factor 4A-1 0.0599 0.5 0.5
Giardia lamblia Translation initiation factor eIF-4A, putative 0.0599 0.5 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0599 0.5 0.5
Leishmania major eukaryotic initiation factor 4a, putative 0.0599 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) 0 Evaluated for the ovulation effects in the rat by administering the drug at the doses (10 ug); 2/8 ChEMBL. 10715147
Activity (functional) 0 Evaluated for the ovulation effects in the rat by administering the drug at the doses (25 ug); 3/8 ChEMBL. 10715147
Activity (functional) 0 Evaluated for the ovulation effects in the rat by administering the drug at the doses (50 ug); 2/9 ChEMBL. 10715147
Ki (binding) = 0.32 nM Competitive radioligand binding assay, in human HEK-293 cells stably transfected with the rat Gonadotropin-releasing hormone receptor ChEMBL. 10715147
Ki (binding) = 0.32 nM Competitive radioligand binding assay, in human HEK-293 cells stably transfected with the rat Gonadotropin-releasing hormone receptor ChEMBL. 10715147

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.